Biogen Idec, Inc. (Massachusetts)’s New AVONEX?? Dosing Innovations for People with Multiple Sclerosis Now Available in US

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) announced that two new dosing innovations designed to help patients receiving once-a-week AVONEX (interferon beta-1a) for relapsing forms of…
Read the full story: BioSpace.com Featured News